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Recent advances indicate a possible role of phytochemicals as modulatory factors in signaling pathways.
We have previously demonstrated PHLPP2-mediated suppression of Nrf2 responses during oxidant at-
tack. The present study was designed to explore Nrf2-potentiating mechanism of morin, a ﬂavonol, via its
possible role in intervening PHLPP2-regulated Akt/GSK3β/Fyn kinase axis. Efﬁcacy of morin was eval-
uated against oxidative stress-mediated damage to primary hepatocytes by tert-butyl hydroperoxide
(tBHP) and acetaminophen. The anti-cytotoxic effects of morin were found to be a consequence of for-
tiﬁcation of Nrf2-regulated antioxidant defenses since morin failed to sustain activities of redox enzyme
in Nrf2 silenced hepatocytes. Morin promoted Nrf2 stability and its nuclear retention by possibly
modulating PHLPP2 activity which subdues cellular Nrf2 responses by activating Fyn kinase. Pull-down
assay using morin-conjugated beads indicated the binding afﬁnity of morin towards PHLPP2. Molecular
docking also revealed the propensity of morin to occupy the active site of PHLPP2 enzyme. Thus, dietary
phytochemical morin was observed to counteract oxidant-induced hepatocellular damage by promoting
Nrf2-regulated transcriptional induction. The ﬁndings support the novel role of morin in potentiating
Nrf2 responses by limiting PHLPP2 and hence Fyn kinase activation. Therefore, morin may be exploited in
developing novel therapeutic strategy aimed at enhancing Nrf2 responses.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Reactive oxygen and nitrogen species (ROS/RNS) have theB.V. This is an open access article
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gmail.com (P. Kakkar).capacity to act as signaling moieties involved in maintenance of
cellular homeostasis [1]. However, their accumulation within the
cell may lead to oxidative imbalances, altered homeostasis and
subsequent cell death. Such an occurrence is prevented through a
coordinated defense network, such as the Antioxidant Response
Element (ARE)/Nrf2 pathway, that guards the cellular makeup
from a possible oxidative insult. When confronted with oxidant
challenge, Nuclear factor-erythroid 2 p45-related factor 2 (Nrf2),
translocates to the nucleus, where, in association with other pro-
teins, it keeps a panel of cytoprotective genes under its tight
regulation [2]. Nrf2 is activated and translocated to the nucleus
evenwhen a mild rise in oxidative load is sensed [3]. However, any
irregularity in its mechanism potentiates free radical-induced
stress, thereby disturbing normal cellular physiology.
Perturbed Nrf2 activity has been associated with the progres-
sion of a number of pathological conditions involving oxidative
imbalances [4–6]. Our previous ﬁndings on oxidative toxicity im-
posed by tert-butyl hydroperoxide (tBHP) [7] documented sup-
pression in cellular Nrf2 responses due to induction of PH domain
Leucine-rich repeat Protein Phosphatase 2 (PHLPP2) whichunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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(PHLPP1 and PHLPP2) regulate the PI3K signaling by selective
dephosphorylation (of Akt Ser473 residue) and hence down-
modulation of Akt activity [8]. The phosphatidylinositol-3 kinase
(PI3K) signaling is well known to play a pivotal role in maintaining
cellular homeostasis. Due to its central role in deactivation of Akt,
PHLPP is viewed as an attractive drug target for positive or nega-
tive regulation of PI3K signaling in disease [9]. Owing to the in-
hibitory effect of PHLPP2 on Nrf2 activity [7], checking PHLPP2
activity may prove beneﬁcial under circumstances where Nrf2
signaling is muted due to increased Nrf2 destabilization.
The functional integrity of Nrf2-regulated antioxidant and de-
toxiﬁcation system is of utmost importance for the maintenance of
hepatic physiology. At present, dietary phytoconstituents that
could assist in alleviating oxidative stress-associated repercussions
are increasingly being sought-after [10,11]. Plant-derived phyto-
chemicals are now widely accepted as important dietary factors
that boost our health by protecting cells against oxidative damage.
The wide range of health promoting effects of these phytochem-
icals has often been attributed to the induction of Nrf2 pathway
[12]. Morin (2′,3,4′,5,7-pentahydroxyﬂavone), a ﬂavonol, has been
shown to possess a wide array of biological activities including
anti-oxidant [13], anti-hyperglycaemic [14] and hepato-protective
[15] properties. Though its role as an antioxidant or free-radical
scavenger in promoting cytoprotection has been established, no
study has yet addressed its function as modulator of Nrf2-medi-
ated signaling pathways to counter cytotoxicity arising due to
oxidative stress.
Hence, the present study was aimed at deﬁning the mechan-
istic involvement of morin in mitigation of dysregulated Nrf2 re-
sponses during an event of oxidant attack by employing tBHP as an
oxidative stress generating agent. Further, the cytoprotective me-
chanism of morin investigated in oxidatively compromised (tBHP-
treated) hepatocytes was also conﬁrmed in hepatocytes exposed
to cytotoxic concentrations of acetaminophen (APAP).2. Materials and methods
2.1. Materials and reagents
Antibodies and chemicals including ERK1/2 (4695), phospho-
ERK1/2 (9101), SAPK/JNK (9252), phospho-SAPK/JNK (4668),
phospho-Akt Ser473 (4060), phospho-Akt Thr308 (2965), phos-
pho-GSK3β Ser9 (9323), phospho-PDK1 Ser241 (3438), phospho-
PTEN Ser380 (9551), Cox-IV (11967), anti-rabbit Alexaﬂuor 555
conjugate (4413) were purchased from Cell Signaling Technology
(Danvers, MA). Antibodies against caspase-12 (ab62484), HMGB1
(ab79823) and NALP3 (ab17267) were obtained from Abcam
(Cambridge, UK). FBS, 100X antimycotic and antibiotic solution,
Collagenase (type IV), OPTI-MEM reduced serum medium, Wil-
liam's medium E, Lipofectamine RNAiMAX Transfection Reagent,
CellTracker™ Green CMFDA dye and antibody against caspase-1
(AHZ0082) were procured from Invitrogen (Carlsbad, CA). Silencer
Select Pre-designed siRNA against Nfe2l2 (ID:s136127), negative
control unlabeled siRNA were supplied by Ambion (Austin, TX).
Chemicals and antibodies like Nrf2 (sc-30915), Keap1 (sc-33569),
β-actin (sc-81178), GAPDH(sc-25778), Ubiquitin (sc-166553), La-
min b (sc-6216), HO1 (sc-10789), NQO1 (sc-16463), Akt1 (sc-
5298), Fyn kinase (sc-16-G), caspase-3 (sc-7148), caspase-9 (sc-
8355), Bax (sc-493), Bcl2 (sc-492-G), cytochrome c (sc-8385),
agarose conjugated phospho-Thr antibody (sc-5267AC), secondary
antibodies, normal goat sera and Protein A/G PLUS Sepharose
beads were purchased from Santa Cruz Biotechnology (Santa Cruz,
CA). CNBr-activated Sepharose beads were purchased from GE-
Healthcare (GE Healthcare BioSciences Ltd., Kowloon, Hongkong).All other reagents or chemicals including acetaminophen, morin
hydrate, tBHP, PHLPP2 antibody (SAB1300919), anti-goat FITC
conjugated secondary antibody (F7367), Hoechst 33258 and dex-
amethasone were procured from Sigma (St Louis, MO, USA) unless
otherwise mentioned.
2.2. Primary rat hepatocytes isolation, culture and treatment
Primary hepatocytes were isolated from male wistar rats
weighing 100–120 g, 6- to 8-week-old through portal vein col-
lagenase perfusion of liver as per the method of Seglen [16]. Rats
were procured from the animal house of CSIR-Indian Institute of
Toxicology Research. All rats were housed in environmentally
controlled rooms under standard conditions of humidity 60–70%,
temperature 2572 °C and a 12 h light/dark cycle. Animal handling
in all experimental procedures was approved by the Institutional
Animal Ethics Committee (Ref no. ITRC/IAEC/20/09-01/11-33/12).
Hepatocytes were seeded on collagen-coated surface and were
cultured for 4 h in William's medium E supplemented with
50 nmol/l dexamethasone and 5% fetal bovine serum (FBS) in ad-
dition to 2 mmol/l glutamine. Thereafter, the cells were cultured in
the same medium lacking dexamethasone and FBS. tBHP was
freshly prepared in culture medium while morin stock solution
was prepared in dimethyl sulfoxide (DMSO) and thereafter diluted
in culture medium taking care that DMSO concentration does not
exceed 0.01% in any of the treatments. Cytoprotective efﬁcacy of
morin against tBHP was tested by treating hepatocytes with dif-
ferent concentrations of morin in combination with tBHP stress. In
case of morin pre-treatment, hepatocytes were exposed to se-
lected concentration of 10 mMmorin for different time periods and
washed with fresh media before subsequent treatment with tBHP.
In experiments involving acetaminophen (APAP), hepatocytes
were treated with 1 mM APAP (prepared by dissolving in media)
for 90 min. A concentration of 10 mM morin was tested for its ef-
ﬁcacy against APAP. Cell viability was estimated by determining
the reduction of 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenylte-
trazolium bromide (MTT) to formazan. The absorbance corre-
sponding to that of untreated control cells was assumed as 100%
cell viability.
2.3. Measurement of intracellular reactive oxygen species (ROS)
Intracellular ROS generation was estimated using 2′,7′-di-
chloroﬂuorescein diacetate (DCFH-DA). Brieﬂy, hepatocytes plated
at a density of 10,000 cells/well were incubated with DCFH-DA
(10 mM) for 30 min at 37 °C prior to treatment with tBHP and/or
morin. In case of morin pre-treatment, DCFH-DA (10 mM) was
added 30 min prior to end of 3 h incubation with morin. Mea-
surements were taken at different time periods during the course
of the treatment schedule using Varioskan Flash Multimode mi-
croplate reader (Thermo Fisher Scientiﬁc) at 485 nm excitation
and 530 nm emission.
2.4. Measurement of glutathione (GSH) levels
For glutathione estimation, CellTracker™ Green CMFDA dye (5-
Chloromethylﬂuorescein Diacetate; Invitrogen) was used, which
detects GSH with a speciﬁcity of 95%. Cells were incubated with
5 mM CMFDA at 37 °C prior to treatment and measurements were
made at different time periods at excitation wavelength of 492 nm
and emission wavelength of 517 nm using Varioskan Flash Multi-
mode microplate reader (Thermo Fisher Scientiﬁc).
2.5. Evaluation of mitochondrial membrane potential
Cells were treated with 5 mM 5,5′,6,6′-tetrachloro-1,1′,3,3′-
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similar to that mentioned above. The green to red shift in ﬂuor-
escence was measured at different time periods during the course
of the treatment using Varioskan Flash Multimode microplate
reader. The results are expressed as red/green ﬂuorescence ratio
measured at 515 nm/529 nm (excitation/emission) for green and
515 nm/530 nm (excitation/emission) for red JC-1 aggregates.
2.6. Measurement of intracellular calcium levels
Fura 2-AM dye was used to evaluate intracellular calcium le-
vels. The hepatocytes were treated with 5 mM Fura 2-AM for
30 min at 37 °C and treated in a similar manner as for ROS esti-
mation. The calcium-free or unbound fura dye was monitored at
380 nm excitation and 510 nm emission wavelengths while the
calcium-bound dye was measured at 340 nm excitation and
510 nm emission wavelengths using Varioskan Flash Multimode
microplate reader. The 340/380 ratio was calculated to determine
calcium levels at different time intervals during treatment period.
2.7. DCF/DHE staining
For ﬂuorescent microscopic detection of ROS, hepatocytes were
stained with 10 mM DCFH-DA and 5 mM DHE. Hoechst 33258 was
used to stain nuclei and observed under Nikon ECLIPSE 80i upright
microscope (Nikon Corporation, Japan) using 10 objective
magniﬁcation.
2.8. Measurement of caspases activity
The activity of caspases namely, caspase-3, caspase-9 and cas-
pase-12 were determined using the Caspase-3 Colorimetric Assay
Kit, Caspase-9 Colorimetric Assay Kit and Caspase-12 Fluorometric
Assay Kit (BioVision, Inc., Mountain View, CA), respectively, as per
the manufacturer's instruction.
2.9. Immunocytochemistry
Cells were washed with cold 0.01 M PBS (pH 7.2) and ﬁxed in
4% paraformaldehyde for 10 min. The cells were then washed with
0.05% glycine in PBS and then permeabilized with 1% Triton X-100
(v/v in PBS) for 15 min followed by overnight incubation with anti-
Nrf2 antibody at a dilution of 1:200 in PBS, the cells were rinsed
thrice with PBS for 5 min each. This was followed by 3 h incuba-
tion in FITC-conjugated secondary antibody at 1:500 dilution.
Nuclei were counter-stained with Hoechst 33258 (1 mM) for
15 min. Cells were observed under Nikon ECLIPSE Ti-S inverted
microscope (Nikon Corporation, Japan) under 40 objective.
2.10. Sub-cellular fractionation
Isolation of nuclear and cytoplasmic fractions from hepatocytes
was achieved using NE-PER extraction kit (Pierce, Thermo Scien-
tiﬁc). Concentration of protein was determined using Bicincho-
ninic acid (BCA) method.
2.11. Enzyme activities
To obtain cell lysate for estimation of enzyme activity, primary
hepatocytes were suspended in 50 mM Tris–Cl (pH 7.4) containing
0.1% Nonidet P-40, 150 mM NaCl and Protease inhibitor cocktail.
The cells were gently agitated at 4 °C for about 1 h and thereafter
centrifuged at 16,000g to obtain cell lysate
Glutathione reductase activity (EC 1.8.1.7): Glutathione reductase
activity was measured as the amount of NADPH consumed in re-
ducing GSSG to GSH. Brieﬂy, the activity was measuredspectrophotometrically (Ultrospec 3100pro) at 340 nm after add-
ing 1 mM GSSG to a reaction system containing 0.2 mM NADPH in
0.1 M Tris–Cl (pH 7.5) and cell lysate containing 40 mg protein
sample. Absorbance was recorded at every 30 s interval for 3 min
at 25 °C (Extinction coefﬁcient for NADPþ¼6.22 mM1 cm1).
Thioredoxin reductase activity (EC 1.8.1.9): Thioredoxin reductase
activity was determined spectrophotometrically using 5,5′-di-
thiobis (2-nitrobenzoic acid) (DTNB). Thioredoxin reductase cata-
lyses the reduction of oxidized thioredoxin while converting DTNB
to TNB (5-Thio-2-Nitrobenzoic Acid) in the process. Reaction
mixture containing 0.25 mM NADPH and 7 mM EDTA in 0.2 M
sodium phosphate buffer (pH 7.2) was prepared. Protein sample
(40 mg) was added to 400 ml reaction mixture and the reaction was
initiated by adding 400 ml of 8 mM DTNB in a cuvette. Increase in
absorbance was measured on Ultrospec 3100pro UV/visible spec-
trophotometer (Amersham Biosciences, Sweden) at 412 nm at a
regular interval of 60 s for about 5 min at 25 °C. Enzyme activity
was calculated as mM TNB formed/min/mg protein (Extinction
coefﬁcient of TNB¼13,600 M1 cm1).
Glutathione peroxidase activity (EC 1.11.1.9): Reaction mixture
containing 1 mM EDTA in 50 mM potassium phosphate buffer (pH
7.0) was prepared. Cell lysates containing 40 mg protein samples
were incubated with 340 ml reaction buffer, 60 ml 10 mM GSH, 60 ml
glutathione reductase (2.4 U/ml) and 60 ml 1.5 mM NADPH at 37 °C
for 3 min. Thereafter, reaction was initiated by adding 60 ml of 2 mM
H2O2 and absorbance measured at 340 nm for 5 min at 60 s interval
(Extinction coefﬁcient for NADPþ¼6.22 mM1 cm1).
NQO1 activity (EC 1.6.5.2): NQO1 activity was assayed using a
two-electron acceptor dichloroindophenol (DCIP). Reaction mix-
ture containing 50 mM Tris–Cl (pH 7.5), 0.08% Triton X-100,
0.25 mM NADPH and 80 mM 2,6-dichloroindophenol (DCIP) was
prepared. To an assay cuvette containing 40 mg/ml protein sample,
the reaction started by the addition of 0.695 ml of reaction mix-
ture. The two-electron reduction of DCIP was monitored kineti-
cally at 600 nm at 25 °C for 3 min. Activity was calculated as nM
DCIP reduced/min/mg protein (Extinction coefﬁcient of reduced
DCIP¼21 mM1 cm1).
Glutathione-sulfotransferase activity: The activity was estimated
using CDNB (1-chloro-2,4-dinitrobenzene), a synthetic GST sub-
strate. The assay measures conjugation of CDNB with reduced
glutathione. To 380 ml of 105 mM potassium phosphate buffer (pH
6.5), 4 ml 100 mM GSH was added followed by addition of cell ly-
sate containing 40 mg protein sample. 4 ml of 100 mM CDNB (pre-
pared in methanol) was added and change in absorbance recorded
at 340 nm for 5 min at 60 s interval (Extinction coefﬁcient of GS-
DNB conjugate¼9.6 mM1 cm1).
2.12. siRNA transfection
Silencer Select predesigned siRNA against rat Nfe2l2 (Nrf2) was
obtained from Ambion. Transfection was performed in Opti-MEM
Reduced Serum Medium (Gibco) 24 h after plating using Lipo-
fectamine RNAiMAX Transfection Reagent in agreement with
manufacturer's instructions. After 4 h incubation, the transfection
medium was changed with serum-supplemented medium and the
hepatocytes were further cultured for additional 20 h. Western
blot analysis revealed an approximate 50–60% knockdown of Nrf2
post 24 h transfection with 50 nM siRNA concentration compared
to negative control siRNA. A concentration of 50 nM siRNA was
selected for further experiments. Stimulations by tBHP and morin
were done 48 h after plating.
2.13. TransAM Nrf2-ARE binding assay
The Nrf2-DNA binding activity was measured using ELISA-
based assay (TransAM kits, Active Motif, Carlsbad, CA) following
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the nuclear lysates were prepared by lysing the nuclei obtained
from liver tissue as per the method described above.
2.14. Immunoprecipitation and immunoblotting to detect Nrf2
ubiquitination
Non-denaturing immunoprecipitation was performed by
bringing about the lysis of cells in 1 ml of radio immune pre-
cipitation assay buffer (RIPA) for 30 min at 4 °C, scraped followed
with centrifugation at 16,000g for 20 min at 4 °C. The supernatant
was rotated with anti-Nrf2 antibody overnight at 4 °C on rocker.
Protein A/G PLUS (Santa Cruz Biotechnology) was added (30 μl),
and samples were incubated for 2 h at 4 °C. Immunoprecipitates
thereafter were pelleted, washed three times with 1 ml of radio-
immune precipitation assay (RIPA) buffer, boiled in Laemmli buffer
and were analyzed by western blotting with anti-ubiquitin anti-
body [7].
2.15. Immunoblot analysis
Hepatocytes were pelleted, washed with ice-cold phosphate-
buffered saline (PBS) and lysed in NP-40 lysis buffer to obtain total
cellular protein. The supernatant was collected by centrifuging at
17,000g for 15 min and stored in aliquots at 80 °C. Protein con-
centration was estimated using Bicinchoninic acid (BCA) method.
40–50 mg protein samples were resolved by 10% SDS-PAGE and
thereafter transferred onto polyvinylidene ﬂuoride (PVDF) mem-
brane (Hybond-P, Amersham Biosciences, Piscataway, NJ). Im-
munoblot was visualized using Immobilon western chemilumi-
nescent horseradish peroxidase substrate kit (Millipore Corpora-
tion, Billerica, MA, USA). Chemiluminescence signals were cap-
tured using Versa Doc image analyzer (Bio-Rad, Hercules, CA, USA)
and protein expression levels were analyzed using ImajeJ 1.44p
software (National Institute of Health, Bethesda, MD, USA).
2.16. Docking study
To get the insight into the binding mode of Morin with PP2C
domain of PHLPP2, we performed docking of Morin to PP2C do-
main. The structure of Morin was built with sketch module of
Sybyl7.1 (Sybyl, Version 7.1, Tripos, Inc., St. Louis, MO, 2005). The
structure of Morin was geometrically optimized within Sybyl7.1
using MMFF94 force ﬁeld and MMFF94 charges with 1000 itera-
tions. AutoDock4.2 [17] was used to dock Morin into the binding
site of homology model of PP2C domain of PHLPP2 protein that
has been published by Sierecki et al. [18]. The molecular docking
study of Morin with Fyn kinase was also performed using Auto-
dock4.2 software. The crystal structure of Fyn kinase was obtained
from RCSB protein data bank (Accession code: 2DQ7) [19]. All the
structure visualization was performed using Chimera [20].
2.17. Morin-conjugation to sepharose beads and pull-down assay
Preparation and coupling of beads with morin: Approximately,
300 mg lyophilized CNBr-activated Sepharose 4B powder was
weighed and suspended in 10 ml of 1 mM HCl. The swollen beads
were thereafter washed for 15 min with 1 mM HCl (by giving 10
washes of 10 ml each) and ﬁnally with coupling buffer (0.1 M
NaHCO3 pH 8.3, 0.5 M NaCl). The mediumwas equally divided into
two, one for blank and the other for coupling morin. 2 mg morin
was weighed and dissolved in 100 mL DMSO, thereafter coupling
buffer was added to make up the volume to 1.5 ml. The solution of
morin was added to the beads medium. To the medium labeled as
blank, 1.5 ml of coupling buffer with 100 mL DMSO was added. The
suspension was rocked overnight at 4 °C. Washing and blockingsteps were performed as directed by the manufacturer. The entire
process was followed with blank beads medium as well.
Pull-down reaction: The beads were washed twice with reaction
buffer (50 mM Tris pH 7.5, 5 mM EDTA, 150 mM NaCl, 1 mM DTT,
0.01% NP-40, 2 mg/ml BSA, 0.02 mM PMSF and protease inhibitor
cocktail). Approximately, 100 mg of cell lysate was incubated with
50 ml packed volume of both morin-conjugated as well as blank
beads separately and suspended in reaction buffer. The tubes were
rotated end-over-end overnight at 4 °C. The proteins pulled down
along with the beads were washed thrice with reaction buffer,
boiled in 2 SDS loading dye and applied to 10% SDS-PAGE along
with a separate well for 50 mg cell lysate. The proteins were
transferred onto PVDF membrane, which was later probed with
antibodies against PHLPP2 and Fyn kinase.
2.18. Statistical analysis
All computational calculations of quantitative data were per-
formed using Microsoft Excel program. Each experiment was re-
peated at least three times. The quantitative variables represented
in histograms are expressed as mean7SEM. Statistical compar-
isons between means of different groups were conducted by one-
way Analysis of Variance (ANOVA) followed by Tukey's post hoc
test using SPSS 14.0 statistical package (SPSS Inc., Chicago, IL, USA).
Differences were considered statistically signiﬁcant when Po0.05.3. Results
3.1. Morin directly protects hepatocytes against oxidative stress in-
duced cell death
To explore the key protective mechanism behind its role as an
antioxidant, we investigated whether morin could protect isolated
hepatocytes from toxicity generated due to oxidative overload. For
this we employed tBHP (tert-butyl hydroperoxide), a pro-oxidant,
wherein GSH depletion is believed to be a prime causative factor
in the cytotoxicity ensued by oxidative stress [21]. 250 mM con-
centration of tBHP at 90 min exposure was selected for studies
involving cytoprotection by morin since this concentration was
observed to establish signiﬁcant cell death due to oxidative stress
[7] which is indicative of collapse in cellular defensive mechan-
isms. Three different non-cytotoxic concentrations of morin, 5 mM,
10 mM and 15 mM, were co-administered with 250 mM tBHP. Co-
treatment of hepatocytes with 10 mM morin exhibited signiﬁcant
improvement in the cell survival rate reaching 97.7% (Po0.05;
Fig. 1A). For pre-treatment studies with morin, a pre-incubation
period of 3 h was found to be effective in exerting protective ef-
fects upon subsequent 90 min exposure of 250 mM tBHP (Fig. 1B)
which increased the viability of hepatocytes to 93.5%. The im-
proved cell survival capacity was observed to be a result of sup-
pressed intracellular ROS levels as estimated by DCF ﬂuorescence
(Fig. 1C). Apart from preventing collapse of mitochondrial mem-
brane potential (Fig. 1D), treatment with morin also precluded
alterations inGSH and intracellular calcium levels (Fig. 1E and F).
3.2. Morin prevents tBHP-evoked modulation in levels of pro-apop-
totic and Erk-JNK proteins
While loss of mitochondrial membrane potential results in
sequential activation of caspase-9 and caspase-3, activation of
caspase-12 is a key hallmark of endoplasmic reticulum stress ac-
companied by alterations in calcium homeostasis. The reduction in
oxidative burden correlated well with suppression of tBHP-evoked
caspases activation (Fig. 2A and B). While morin co-treatment
appreciably prevented Bax accumulation, both morin co- as well
Fig. 1. Morin prevents tBHP-induced death and oxidative stress in primary hepatocytes. Cell viability was determined using MTT assay in primary rat hepatocytes (1104
cells/well) treated with (A) 250 mM tBHP together with non-cytotoxic doses (5, 10 or 15 mM) of morin for 180 min, (B) time-dependent (1 h, 2 h and 3 h) exposure to 10 mM
morin followed by 90 min treatment with 250 mM tBHP. The data are represented as mean7SEM of three independent experiments. nPo0.05 vs. control; #Po0.05 vs. tBHP
treatment. Effect of morin in preventing (C) intracellular ROS generation and (D) mitochondrial membrane permeabilization was assessed by incubating hepatocytes with
10 mM DCFH-DA or 5 mM JC-1 respectively for 30 min at 37 °C. Fluorescence was determined at the mentioned time-points upto 3 h. (E and F) Morin maintains GSH pool and
intracellular calcium levels of tBHP-treated primary hepatocytes. Hepatocytes were treated with 5 mM CMFDA (E) or 5 mM Fura 2-AM (F) for 30 min at 37 °C. The cells were
rinsed and treated with 250 mM tBHP (tBHP) for 90 min either in combination with 10 mM morin (tþMo) or following prior 3 h incubation with 10 mM morin (MoPre).
Fluorescence was determined at the mentioned time-points upto 3 h. The data are represented as mean7SEM of three independent experiments. nPo0.05 vs. control;
#Po0.05 vs. tBHP treatment.
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ering tBHP-mediated increase in cytosolic cytochrome c levels
(Fig. 2A). Erk1/2 can regulate cell survival and apoptotic mechan-
isms by inﬂuencing the activity of anti- and pro-apoptotic tran-
scription factors [22]. Moreover, its phosphorylation levels are
found to be negatively inﬂuenced by pro-oxidant exposures
[23,24]. The decrease in Erk1/2 phosphorylation and increased
phosphorylation of SAPK/JNK in response to tBHP stimulus was
prevented by morin supplementation (Fig. 2C). The potential of
morin to inﬂuence molecular signaling events can be gauged from
the observation that treating hepatocytes with morin alone also
increased phosphorylation of Erk1/2 while reducing that of SAPK/
JNK in a time-dependent manner (Fig. 2C). Studies involving
phytochemicals like sulforaphane [25], quercetin [26], genistein
[27] have shown that activation of MAP kinases like Erk, JNK or
PI3K/Akt pathway may be involved in Nrf2 transactivation which
subsequently fortiﬁes cellular antioxidant defenses. The results, inaggregate, demonstrate that morin's capacity to limit oxidative
stress plays a key role in promoting cytoprotection against oxidant
challenge apart from its potential to limit ER stress ensued damage
via Erk-Nrf2 pathway [28].
3.3. Morin induced cytoprotection against oxidative stress is Nrf2-
regulated
In our earlier report [7], we have demonstrated the contribu-
tion of suppressed Nrf2 responses to deterioration of cellular de-
fense system, ultimately resorting to death of oxidant-exposed
hepatocytes. We reckoned that the cytoprotective efﬁcacy of
morin against oxidative damage might be a manifestation of its
capacity to potentiate Nrf2-regulated survival pathway. Treatment
of tBHP-stressed hepatocytes with morin displayed a consistent
increase in the protein level of target enzymes of Nrf2 that is,
NQO1 and HO1 (Fig. 3A). Microscopic evaluation revealed notable
Fig. 2. Morin modulates tBHP-mediated oxidative stress and the consequent alteration in protein levels of cell death pathways. Primary rat hepatocytes were treated with
250 mM tBHP (tBHP) for 90 min and either in combination with 10 mM morin (tþMo) or following prior 3 h incubation with 10 mM morin (MoPre). (A) Western blot images
depict levels of caspase-3, caspase-9, caspase-12, Bax and Bcl2 in whole cell extracts and cytochrome c in cytosolic extracts. Results were normalized to β-actin. Values
indicate fold change in band density relative to respective control values. (B) Activity of caspase-3, caspase-9 and caspase-12 estimated in cytosolic extracts using colorimetry
or ﬂuorimetry based assays. (C) Representative immunoblots showing effect of morin on activation of Erk1/2 and SAPK/JNK in primary rat hepatocytes. β-actin served as a
loading control. The change in phosphorylation was quantitated relative to their non-phosphorylated forms, following which; fold change in band density was obtained
relative to respective control values. The data are represented as means7SEM of three independent experiments. nPo 0.05 vs. control; #Po0.05 vs. tBHP/APAP treatment.
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morin as indicated by enhanced ﬂuorescence under green channel
corresponding to the nuclear region depicted by Hoechst staining
(Fig. 3B, tþMo). In case of pre-treatment, the density of Nrf2
within the nucleus exhibited considerable improvement over
tBHP-treated hepatocytes but was less pronounced as compared to
co-treated cells.
3.4. Morin promotes nuclear retention of Nrf2 by promoting its
stability
To determine whether morin is individually capable of inducing
nuclear translocation of Nrf2, we studied the distribution of Nrf2
in nuclear and cytoplasmic fractions of unstressed hepatocytes
treated with 10 mM morin alone for 1 h, 2 h and 3 h. Western blot
analysis revealed time dependent increase in nuclear Nrf2 density
with approximately 3.6 fold increase at 3 h exposure (Fig. 4A).
Distribution of Nrf2 in the cytoplasmic fraction, however, showed
no change with time. Immuno ﬂuorescent detection also sup-
ported the western blot data (Fig. 4B). Further, morin did not alter
the levels of Keap1 in both cytosolic and nuclear fractions (Fig. 4A).This signiﬁes that morin may have promoted nuclear accumula-
tion of Nrf2 via a pathway distinct from Keap1-regulated Nrf2
turnover.
Apart from nuclear import, there are other pathways that dis-
tinctly operate to assist nuclear retention of Nrf2, such as the one
responsible for determining Nrf2 stability. Previous studies have
indicated that enhanced Nrf2 stability transpires increased Nrf2-
activation [29]. As was anticipated, tBHP stress induced consider-
able ubiquitination of Nrf2 (Fig. 5A) which was prevented by
morin. Furthermore, treatment of hepatocytes with morin alone
was also observed to reduce levels of endogenously ubiquitinated
Nrf2 (Fig. 5B). Treatment with tBHP signiﬁcantly reduced the ARE-
binding efﬁcacy of Nrf2 by 25% in comparison to control. While co-
treatment with morin effectively maintained the Nrf2 transcrip-
tional activity comparable to control, pre-treating the hepatocytes
with morin prior to tBHP-evoked oxidative stress led to a sig-
niﬁcant 2 fold increase in nuclear Nrf2-binding activity as com-
pared to tBHP (Fig. 5C). Further, morin signiﬁcantly improved the
tBHP-induced decline in activities of redox and phase-II enzymes
in wild-type hepatocytes (Fig. 5D, tBHPþMo and MoPre). The
activities of antioxidant enzymes were further studied in Nrf2-
Fig. 3. Morin counteracts tBHP-evoked oxidative damage by enhancing nuclear accumulation of Nrf2. (A and B) Primary rat hepatocytes were treated with 250 mM tBHP
(tBHP) for 90 min and either in combination with 10 mM morin (tþMo) or following prior 3 h incubation with 10 mM morin (MoPre). (A) Effect of morin on protein
expression of Nrf2 and its downstream targets. (B) Immunoﬂuorescent staining of primary hepatocytes depicting Nrf2-compartmentalization in hepatocytes. Scale bar,
20 mm.
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results revealed signiﬁcant decrease in the activities of all the
enzymes during in Nrf2-silenced hepatocytes due to tBHP ex-
posure irrespective of morin treatment (co- or pre-). This suggests
that the reinforcement of the antioxidant defenses of cell due to
morin treatment is not a result of its antioxidant potential alone
but due to potentiation of Nrf2-regulated transcriptional induc-
tion. We may thus assume that Nrf2-mediated up-regulation of
antioxidant and detoxiﬁcation enzymes observed due to morin
can be explained, at least in part, by enhancement of Nrf2 stability
leading to its increased nuclear retention and ARE-Nrf2 binding
afﬁnity.
3.5. Suppression of PHLPP2 activity accounts for cytoprotective efﬁ-
cacy of morin against oxidant stress
We have previously proven and discussed the involvement of
Fyn kinase in determining Nrf2 stability via PHLPP2-Akt (Ser473)-
GSK3β pathway [7]. Since, morin treatment was observed to at-
tenuate Nrf2 ubiquitination, we reckoned that the protection ac-
corded by morin, by way of potentiating Nrf2 signaling, might
involve modulation of PHLPP2-regulated Fyn kinase activation. In
agreement to our hypothesis, morin prevented tBHP-induced
phosphorylation of Fyn kinase by limiting PHLPP2-mediated de-
activation of Akt at Ser473 residue (Fig. 6A). This in turn in-
activated GSK3β, which promotes Fyn kinase phosphorylation
when active. Nuclear levels of phosphorylated Fyn kinase were
also reduced by morin supplementation (Fig. 6B). Pull-down assayevidenced the structural interaction of morin with both Fyn kinase
and PHLPP2 which are negative upstream modulators of Nrf2-ac-
tivation (Fig. 6C).
Treatment of hepatocytes with 10 mM morin alone for in-
creasing time periods (1 h, 2 h and 3 h) did not have any effect on
PHLPP2 expression as revealed by immunoblot experiments
(Fig. 6D). However, signiﬁcant increase upto 1.8 fold (Po0.05) in
phosphorylation of Akt at Ser473 residue could be detected at 3 h.
Further, phosphorylation of GSK3β was also enhanced in a time-
dependent manner reaching 2 fold at 3 h in comparison to control
(Fig. 6D). Morin treatment for 3 h also signiﬁcantly suppressed
phosphorylation of Fyn kinase by 42% (Po0.05). These changes
were accompanied by time-dependent increase in cellular Nrf2
levels. The experimental evidence from western blot analysis re-
veals that morin could exert notable intervention in Nrf2 signaling
pathway by preventing Fyn-kinase phosphorylation and hence
reduced Nrf2 degradation.
Morin was docked to ATP-binding site of Fyn kinase domain in
complex with an inhibitor staurosporine (Fig. 6E). The binding
mode of morin in docked conformation with Fyn kinase was found
similar to that observed in the crystal structure. Morin was ob-
served to be involved in several hydrogen bonds with Met344,
Thr341, Glu342 and Lys298 residues in the ATP-binding site of Fyn
kinase. It has been reported earlier that these interactions play
important role in ligand-binding to Fyn kinase [30]. The docking
experiment corroborates the previous ﬁnding where morin was
shown to inhibit Fyn kinase activity [31]. The ﬁndings would
collectively suggest that Fyn kinase can serve as a potential target
Fig. 4. Morin promotes nuclear retention of Nrf2. (A) Western blot analysis and (B) Immunoﬂuorescent staining of primary hepatocytes to depict Nrf2-compartmentalization
in hepatocytes treated with 10 mM morin alone for 1 h, 2 h and 3 h. Scale bar, 20 mm. The images are representative of three independent experiments. The data are
represented as means7SEM of three independent experiments. nPo0.05 vs. control;
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that morin limited PHLPP2-mediated deactivation of Akt (Fig. 6A)
which lies upstream of Fyn kinase axis. Furthermore, treatment of
hepatocytes with morin alone induced noticeable increase in
phosphorylation of Akt(Ser473) and subsequent targets, without
any apparent alteration in PHLPP2 levels (Fig. 6D). This led us to
posit that morin could have exerted positive inﬂuence on Akt ac-
tivation, and hence Nrf2 signaling, by affecting phosphatase ac-
tivity of PHLPP2, as indicated by pull-down experiment (Fig. 6C).
In an attempt to examine such a possibility, morin was docked into
the binding site of the homology model of PP2C domain of PHLPP2
as identiﬁed by Sierecki et al. [18]. Morin docked well in this
binding site with binding energy of 6.27 kcal/mol. As shown in
Fig. 6E, morin interacts with Asp1024 and Glu989 by hydrogen
bonds in docked complex. Besides these, it also interacts with
Ala986, Asn1025 and Cys948 through hydrogen bonds (Fig. 6F).
These interactions have previously been reported important for
inhibition of activity of PP2C domain [18]. The cumulative ﬁndings
thus indicate that the inhibition of PHLPP2 through structural in-
teraction of morin might be involved in averting suppression of
Nrf2 responses by oxidant exposure.
3.6. Morin prevents acetaminophen induced toxic effects in vitro
To further validate the ﬁndings, the protective action of morin
involving Nrf2 potentiation was dissected in a separate model of
oxidative stress-induced hepatocellular toxicity. Acetaminophen
has previously been reported to cause oxidative damage and
subsequent cell death in primary rat hepatocytes [32]. Isolated
primary rat hepatocytes were exposed to acetaminophen wherein
GSH depletion is proposed to be a critical event in propagatingcellular damage. The concentration of morin (10 mM) found potent
against tBHP was assessed for its efﬁcacy in managing acet-
aminophen (APAP)-induced cell death in-vitro. Apart from rescu-
ing hepatocytes from cell death caused by APAP challenge
(Fig. 7A), morin also reduced cellular ROS levels (Fig. 7B). Treat-
ment with 1 mM APAP for a period of 90 min led to a signiﬁcant
(Po0.05) 30% reduction in viability of hepatocytes which was
prevented by both morin co- and pre-treatment. While simulta-
neous exposure to morin improved the viability by 28.2%
(Po0.05), pre-treatment enhanced cell-survival by 18.4% over that
of APAP-treated values (Fig. 7A). The enhancement in the in-
tensities of green (DCF) and red (DHE) channels detected in APAP-
treated cells was signiﬁcantly suppressed in morin co-treated
hepatocytes (Fig. 7B). Morin pre-treatment also improved cellular
ROS status but the effect was less pronounced as compared to co-
treated hepatocytes. The results demonstrate that morin's capacity
to contain oxidative stress plays a key role in promoting cyto-
protection against APAP-challenge.
The role of morin as small molecule modulator of Nrf2 signal-
ing pathway was assessed by investigating protein expression of
key targets of PHLPP2-regulated pathway. Western blot analysis
(Fig. 7C) revealed 2.7 fold increase in Fyn kinase phosphorylation
together with near 80% decline in GSK3β phosphorylation in
APAP-treated hepatocytes in comparison to control. This was as-
sociated with nearly 61% decrease in pAkt (Ser473) and 1.7 fold
induction of PHLPP2 protein. APAP treatment also down-modu-
lated the protein levels of Nrf2 along with subsequent inhibitory
effects on protein expression of its downstream targets NQO1 and
HO1 (Fig. 7C). Thus, the experiments employing APAP exhibited
similar pattern of activation/deactivation of key proteins involved
in PHLPP2 pathway as observed earlier with respect to tBHP.
Fig. 5. Morin counteracts oxidative damage by promoting Nrf2 stability and activation, thereby strengthening cellular antioxidant defenses. (A) Nrf2 ubiquitination status
was estimated in total cell lysates obtained from tBHP and/or morin treated primary rat hepatocytes as indicated. Nrf2 was immunoprecipitated with anti-Nrf2 antibody
followed by immunoblotting with anti-ubiquitin antibody. A negative control where anti-Nrf2 antibody was replaced with normal goat serum was also included. (B) Nrf2
ubiquitination status in hepatocytes treated with 10 mM morin alone for 1 h, 2 h and 3 h. (C) ELISA-based Nrf2 binding activity in nuclear extracts of treated primary rat
hepatocytes. (D) Enzyme activities were determined in cell lysates obtained from untransfected hepatocytes treated with tBHP and/or morin as well as hepatocytes
transfected with 50 nM Nrf2 siRNA and thereafter exposed to tBHP and/or morin 24 h post-transfection. GR: glutathione reductase; Trx: thioredoxinreductase; GPx: glu-
tathione peroxidase; GST: glutathione sulfotransferase. The data are represented as means7SEM of three independent experiments. nPo0.05 vs. control; #Po0.05 vs. tBHP
treatment; ‡Po0.05 vs. respective tþMo treatments of untransfected cells; ¥Po0.05 vs. respective MoPre treatments of untransfected cells.
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fects on the altered expression of the above proteins. The effect of
morin co-treatment was more pronounced as can be seen from the
30% (Po0.05) reduction in PHLPP2 protein as compared to APAP-
treated cells. Further, the expression of pAKT (Ser473) in APAP-
treated cells was signiﬁcantly enhanced in morin co-treated he-
patocytes together with a profound 71.4% increase in phosphor-
ylation of GSK3β as compared to APAP treatment. The levels of
pFyn and Nrf2 were also restored to near control values. Thus,
morin signiﬁcantly attenuated the regulation imposed by PHLPP2
on Fyn kinase activation during APAP-induced oxidative toxicity
imposed on primary rat hepatocytes.4. Discussion
Oxidative stress has been established as a key factor in hepa-
totoxicity related disorders [33]. Liver, owing to its inherent
function, is under constant risk of xenobiotic stress which is often
claimed to be the primary cause of liver failure. It has long been
believed that supplementation of diet with healthy phytonutrients
may help in the maintenance of liver health. Phytochemicals are
no longer considered mere scavengers of free radicals, but targeted
interventions of molecular pathways are increasingly beingidentiﬁed with their physiological effects [34]. The structural
characteristics of ﬂavonoids not only account for their radical
scavenging activity [35] but also their propensity to modulate
activity of key elements of cell signaling pathways. Hou and Ku-
mamoto [36] have extensively discussed how different ﬂavonoids
can serve as chemopreventive agents by directly binding to and
inhibiting multiple kinases of distinct molecular pathways.
The present study provides fresh set of data, which further
corroborates the notion that the impact of phytochemicals on
physiology is in fact an outcome of direct inﬂuence on molecular
signaling events. Morin appears to exert its cytoprotective activity
by direct interplay with the signaling pathway regulating Nrf2
stability (Fig. 8). PHLPP2 expression is related to increased sus-
ceptibility to cell death. In our previous study [7], we have ex-
plored an association between the toxic implication of PHLPP2
induction and suppression of Nrf2 responses in the liver cells. Akt
activation (its phosphorylation at Ser473 in particular) is known to
inhibit GSK3β by phosphorylating Ser9 residue. This event pre-
vents Fyn kinase activation, which, in its active form, is believed to
mediate Nrf2-suppression via its ubiquitination [30]. In the pre-
sent study, PHLPP2, a phosphatase that exclusively depho-
sphorylates Akt at its Ser473 residue, has been identiﬁed as a novel
target of morin (Fig. 8). By binding to its active domain, morin
subdues the phosphatase activity of PHLPP2. This lifts the
Fig. 6. Morin shows structural afﬁnity towards PHLPP2 and intervenes in PHLPP2-mediated dephosphorylation of downstream effectors. The potential of morin to modulate
key proteins of PHLPP2-regulated pathway was studied and conﬁrmed in tBHP treated hepatocytes. Primary rat hepatocytes were treated with 250 mM tBHP (tBHP) for
90 min and either in combination with 10 mM morin (tþMo) or following prior 3 h incubation with 10 mM morin (MoPre) and key proteins of PHLPP2-regulated pathway
were assessed using western blot analysis. (A) Estimation of protein levels was done in total tissue lysates of tBHP-treated or morin supplemented hepatocytes. β-actin
served as a loading control. (B) Relative levels of phospho-Fyn kinase in the nuclear and cytosolic fractions obtained from hepatocytes treated with tBHP and/or morin.
Lamin-b served as loading control for nuclear samples while GAPDH served as a loading control for cytosolic samples. (C) Pull-down assay demonstrating PHLPP2 and Fyn
kinase binding capacity of morin. CNBr-activated Sepharose beads conjugated with morin were rocked with tissue lysates. Western blots were probed with anti-PHLPP2 and
anti-Fyn kinase antibody. Un-conjugated sepharose beads were also included in the experiment to detect non-speciﬁc binding of protein to beads. (D) Intervention of morin
in PHLPP2-regulated pathway was conﬁrmed in hepatocytes treated with 10 mM morin alone for 1 h, 2 h and 3 h followed by protein isolation and western blot analysis
where β-actin has been used as endogenous control. The data are representative of three independent experiments. (E) Interaction of Morin with Fyn kinase. The protein
residues are shown in Cyan color and Morin is shown in Pink, dash lines represents hydrogen bonds. (F) Interaction of Morin with PP2C domain of PHLPP2. The protein
residues are shown in Grey color and Morin is shown in Pink. Dash lines represent hydrogen bonds. Magnesium ions are shown as purple color spheres. (For interpretation of
the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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Morin has been found to modulate varied protein targets that
may translate into distinct response in different experimental
settings. Strong inhibition of Organic Anion Transporter 1 (OAT1)
by morin [37], for example, identiﬁes its merit in lowering OAT1-
mediated drug nephrotoxicity. Tyrosinase [38], GSK3β [39] and
Fyn kinase [31] are other recent additions to the spectrum of
cellular targets of morin. The capacity of morin to bind multiple
protein targets may explain how morin exerts a wide range of
physiological functions in our body. Interestingly, structural in-
tervention of morin on PHLPP2 (present study) and that on Fynkinase (Fig. 6E) [31] and GSK3β [39], all of which represent up-
stream modulators of Nrf2 signaling, may indicate the immense
potential of morin to ensure activation of cell survival mechanism.
Since each of the identiﬁed targets of morin is regulated by or
regulates multiple other pathways, the selectivity of morin for a
particular enzyme may be subject to the relative levels of each
target. In other words, selectivity of a phytochemical for its
probable targets may depend on context-dependent activation of
speciﬁc signaling pathways as has been suggested earlier [36].
Given the strong antioxidant activity combined with its property
to potentiate cellular survival mechanisms, morin may serve as a
Fig. 7. Morin prevents acetaminophen-mediated cytotoxic effects on primary hepatocytes through intervention in PHLPP2-regulated down-modulation. Acetaminophen-
induced toxicity was estimated in primary rat hepatocytes treated with 1 mM APAP for 90 min. Morin (10 mM) was added either together with (AM) or 3 h prior to APAP
treatment (MPre). (A) The change in cell viability was measured using standard MTT assay. The data are represented as means7SEM of three independent experiments.
nPo0.05 vs. control; #Po0.05 vs. tBHP/APAP treatment. (B) ROS levels were assessed using ﬂuorescence microscopic estimation of DCF/DHE staining. (C) Key proteins of
PHLPP2-regulated pathway were assessed using western blot analysis. Estimation of protein levels was done in total tissue lysates of APAP-treated or morin supplemented
hepatocytes. β-actin served as a loading control.
F. Rizvi et al. / Redox Biology 6 (2015) 587–598 597prospective candidate in designing a combination therapy along
with drugs that pose signiﬁcant chronic or acute toxic effects on
liver. Administration of morin to rats in combination with non-
steroidal anti-inﬂammatory drug, indomethacin, as a therapy for
rheumatoid arthritis yielded better beneﬁcial effects than either of
the drug alone [40]. With the present study we may afﬁrm that by
way of conditioning deleterious responses, we would be in a po-
sition to extract more beneﬁt out of drugs that may elicit oxidative
injury to liver.
In summary, low redox signals fortify the cellular antioxidant
defenses to prevent initiation of a consequent cell death cascade.
However, if the oxidative burden rises to unmanageable levels, it
may produce cytotoxic effects by destabilizing Nrf2 [7]. The study
suggests that morin may adopt two independent modes to curtail
redox imbalances and consequent damage to cellular moieties. In
an event of co-administration with positive oxidative stress in-
ducer, active participation of morin in free radical scavenging ac-
tivity together with prevention of Nrf2 degradation could have led
to subsidence of ROS burden. Experiments involving pretreatment
with morin preclude the possibility of direct interaction with the
oxidant or free radical species but given the potency of morin to
inﬂuence cell signaling pathways, pre-exposure appears to prime
Nrf2 for a rapid antioxidant defense build-up to counteract a
subsequent challenge. Our study identiﬁes a novel role of morin asa small molecule modulator of redox-sensitive signaling pathways
apart from its antioxidant or free-radical scavenging activity. Pull-
down and docking experiments reveal morin's potency to interact
with PHLPP2 and inﬂuence PHLPP2-regulated site-speciﬁc activa-
tion of Akt thereby limiting Fyn kinase activation and its nuclear
translocation. Hence, morin augments cell defense mechanisms
through Nrf2 stabilization as suggested by silencing experiments
wherein morin failed to mount antioxidant defenses against oxi-
dative stress in Nrf2-knockdown hepatocytes. The mitigation of
acetaminophen-induced hepatocytes toxicity by morin through
intervention in PHLPP2-regulated pathway further corroborates its
Nrf2-potentiating role. Apparently, the chemo-preventive me-
chanism followed by morin suggests that, beyond its antioxidant
function, morin is involved in modulation of signaling pathways
that promote Nrf2 stability which suggests that morin may be
exploited to develop novel therapeutic strategy aimed at enhan-
cing Nrf2 responses that could address toxicological changes as-
sociated with xenobiotic stress.Conﬂict of interest
The authors declare no conﬂict of interest.
Fig. 8. Scheme showing mechanism of Nrf2 modulation due to stress/morin
treatment. Under stress conditions (tBHP/APAP), PHLPP2 induction leads to de-
phosphorylation of Akt1 at Ser473 residue which lifts the repression exerted by Akt
on GSK3β. Activated form of GSK3β thereby promotes Fyn kinase activation which
checks Nrf2 levels by mediating its degradation. This leads to ROS build-up and
related toxicological implications. When morin is administered together with stress
(Morin-Co), the protective effects exerted by the phytochemical entail both Nrf2
up-regulation as well as ROS quenching, since morin itself acts as an antioxidant. In
case of addition of morin prior to stress application (Morin-Pre), substantial at-
tenuation of oxidative stress is achieved due to down-modulation of PHLPP2-
regulated Nrf2 suppression.
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